Enterome developed GeneMark-HM software in collaboration with Gene Probe Inc. PARIS, June 16, 2021 /PRNewswire/ -- ENTEROME SA, a clinical stage biopharmaceutical company developing novel drugs based ...

Gen-Probe Inc. (NSDQ:GPRO) bought Waukesha, Wis.-based GTI Diagnostics in a self-funded $53 million cash deal. The acquisition allows the San Diego-based company to expand its transplant diagnostics ...

BRUSSELS, June 3 (Reuters) - U.S. disease diagnosis firm Gen-Probe Inc launched a 215 million euro ($335.4 million) counterbid for Belgian peer Innogenetics NV on Tuesday, trumping an offer from local ...

Hologic ($HOLX) will become a major player in molecular diagnostics focused on sexually transmitted diseases and boost its women's health expertise with the company's ...

LOS ANGELES, July 31 (Reuters) - Gen-Probe Inc Inc said on Thursday its second-quarter net income fell 8 percent as record sales of clinical diagnostics products and blood screening tests failed to ...

Xceed Molecular, a Canadian firm with offices in Wellesley, says it has granted Gen-Probe Inc. a non-exclusive license to use Xceed’s Flow-Thru Chip technology for gene analysis. According to ...

Firm has molecular tests for respiratory infectious diseases. Gen-Probe plans on acquiring Prodesse for approximately $60 million in cash. Achievement of certain financial and regulatory milestones in ...

SAN FRANCISCO (MarketWatch) -- Gen-Probe Inc. Wednesday evening said it has formed an exclusive collaboration with 3M Co. to develop, manufacture and market nucleic acid tests to enhance food safety.

NEW YORK (MarketWatch) -- Gen-Probe Inc. Thursday said it's reached a settlement of its patent litigations and contract arbitrations with Bayer Healthcare LLC, a unit of Bayer Group . The deal calls ...

Background and objectives: The nonisotopic DNA probe assay (PACE 2) was evaluated for the detection of Neisseria gonorrhoeae in urethral and endocervical specimens and compared quantitatively and ...